CommercialCoverageMedium impact
08.02.34, Axatilimab-csfr (Niktimvo™) for Intravenous Use
Independence Blue Cross·Oncology, Hematology, Rheumatology·Pharmacy
Effective date
Jul 28, 2025
We identified it
Jun 19, 2026
Summary
A new pharmacy policy has been established for Axatilimab-csfr (Niktimvo™) for intravenous use. This appears to be coverage guidance for a new medication, likely establishing coverage criteria, prior authorization requirements, or billing procedures for this specific drug therapy.
Action Required
By July 28, 2025: Review the complete policy details at the source URL to understand specific coverage criteria, prior authorization requirements, and billing procedures for Axatilimab-csfr (Niktimvo™). Update billing system and staff training materials accordingly once full policy details are available.